Lampera, Baby Girl .
HRN: 22-56-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/23/2023
03/01/2023
IVTT
16.8mg
Q24h
NEONATAL SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes